Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Schmidt

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass MicrospheresMasao Watanabe, Hong Grafe, Jens Theysohn, et al.
Gastroenterology|March 5, 2002
A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese originMichael Steiner, Kenneth Ocran, Janine Genschel, et al.
Biochimica Et Biophysica Acta|March 18, 2014
The plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cellsPieter Spincemaille, Gursimran Chandhok, Benjamin Newcomb, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 2005
Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progressionChristian Kersting, Arno Kuijper, Hartmut Schmidt, et al.
The British Journal of Radiology|April 22, 2023
Adipopenia in body composition analysis: a promising imaging biomarker and potential predictive factor for patients undergoing transjugular intrahepatic portosystemic shunt placementGeorgios Luca Alatzides, Johannes Haubold, Hannah Luisa Steinberg, et al.
Orphanet Journal of Rare Diseases|September 5, 2015
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose studyOle B Suhr, Teresa Coelho, Juan Buades, et al.
Oncology Research and Treatment|January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Toxicology and Applied Pharmacology|August 20, 2014
The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson diseasePieter Spincemaille, Duc-Hung Pham, Gursimran Chandhok, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood BiomarkersChristoph Kessel, Richard Vollenberg, Katja Masjosthusmann, et al.
Journal of Hepatology|May 25, 2025
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitorsAhmed Ghallab, Mattias Mandorfer, Guido Stirnimann, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass MicrospheresMasao Watanabe, Hong Grafe, Jens Theysohn, et al.
Gastroenterology|March 5, 2002
A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese originMichael Steiner, Kenneth Ocran, Janine Genschel, et al.
Biochimica Et Biophysica Acta|March 18, 2014
The plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cellsPieter Spincemaille, Gursimran Chandhok, Benjamin Newcomb, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 2005
Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progressionChristian Kersting, Arno Kuijper, Hartmut Schmidt, et al.
The British Journal of Radiology|April 22, 2023
Adipopenia in body composition analysis: a promising imaging biomarker and potential predictive factor for patients undergoing transjugular intrahepatic portosystemic shunt placementGeorgios Luca Alatzides, Johannes Haubold, Hannah Luisa Steinberg, et al.
Orphanet Journal of Rare Diseases|September 5, 2015
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose studyOle B Suhr, Teresa Coelho, Juan Buades, et al.
Oncology Research and Treatment|January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Toxicology and Applied Pharmacology|August 20, 2014
The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson diseasePieter Spincemaille, Duc-Hung Pham, Gursimran Chandhok, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood BiomarkersChristoph Kessel, Richard Vollenberg, Katja Masjosthusmann, et al.
Journal of Hepatology|May 25, 2025
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitorsAhmed Ghallab, Mattias Mandorfer, Guido Stirnimann, et al.
Pageof 17